期刊文献+

异维A酸与阿维A治疗扁平疣疗效对比及对IL-2和sIL-2R水平的影响 被引量:8

Efficacy of isotretinoin and acitretin in the treatment of verruca plana and the changes in IL-2 and sIL-2R levels after treatment
在线阅读 下载PDF
导出
摘要 目的:比较异维A酸和阿维A治疗扁平疣的疗效及对IL-2和sIL-2R水平的影响。方法:110例扁平疣患者随机分为A组和B组,各55例,A组口服异维A酸胶丸,B组口服阿维A胶囊,共治疗6周。采用ELISA法检测IL-2和sIL-21水平变化并观察临床疗效。结果:A、B组痊愈率分别为68.51%和64.15%,无显著性差异(P>0.05);6个月复发率分别为5.56%和7.55%,无显著性差异(P>0.05);两组患者治疗后IL-2水平提高,sIL-2R水平下降,与治疗前比较差异有显著性(P<0.05)。A、B组IL-2和sIL-2R水平变化无显著性差异(P>0.05);结论:异维A酸胶丸和阿维A胶囊治疗扁平疣均有好疗效。 Objective:To compare the efficacy and changes in IL-2 and sIL-2R levels of isotretinoin and acitretin in the treatment of verruca plana.Methods:One hundred and ten patients with verruca plana were randomly divided into the group A and group B (55 patients in each group).The patients in group A were treated with isotretinoin and those in group B were treated with acitretin.The course of the treatment was 6 weeks in both groups.The levels of IL-2 and sIL-2R were detected by ELISA and the therapeutic efficacy was clinically assessed.Results:The cure rates of group A and group B were 68.51% and 64.15% respectively,with no significant difference (P>0.05) ;the recurrence rates were 5.56% and 7.55% after follow-up for 6 months,with no significant difference (P>0.05).Compared with the levels of the IL-2 and sIL-2R before the treatment,the level of IL-2 increased and that of sIL-2R declined after the treatment,with significant differences (P<0.05).There was no significant differences in the changes in IL-2 and sIL-2R levels between the group A and the group B (P>0.05).Conclusion:Isotretinoin and acitretinhave equivalent efficacy in the treatment of verruca plana.
出处 《中国麻风皮肤病杂志》 2015年第2期94-96,共3页 China Journal of Leprosy and Skin Diseases
关键词 异维A酸胶丸 阿维A胶囊 扁平疣 isotretinoin acitretin verruca plana
  • 相关文献

参考文献6

二级参考文献28

  • 1吴冠伦.阿维A、卡介菌多糖核酸治疗扁平疣32例效果观察[J].南通大学学报(医学版),2006,26(2):148-148. 被引量:2
  • 2沈俊萍,田文英,张红岩.阿维A治疗扁平疣的疗效观察[J].中国皮肤性病学杂志,2006,20(6):332-332. 被引量:15
  • 3Zouboulis CC.Retinoids--which dermatological indications will benefit in the near future? Skin Pharmacol Appl Skin Physiol,2001,14: 303-315.
  • 4Cather J, Menter A. Novel therapies for psoriasis. Am J Clin Dermatol, 2002, 3:159-173.
  • 5Jackson CG.Immunomodulating drugs in the management of psoriatic arthritis. Am J Clin Dermatol, 2001, 2: 367-375.
  • 6Nyirady J, Grossman RM, Nighland M, et al. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris. J Dermatolog Treat, 2001, 12: 149157.
  • 7Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000.J Am Acad Dermatol,2002,46:505-509.
  • 8Suchin KR, Cucchiara AJ, Gottleib SL, et al. Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution. Arch Dermatol, 2002, 138: 1054-1060.
  • 9Allison DS, El-Azhary RA, Calobrisi SD,et al. Pityriasis rubra pilaris in children. J Am Acad Dermatol, 2002, 47: 386-389.
  • 10Li YH, Gao XH, He CD, et al. Detection of human papillomavirus and response to oral arotinoid ethylester in 2 cases of Darier disease. Arch Dematol, 2002, 138:695-696.

共引文献50

同被引文献67

引证文献8

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部